Creative Led Marketing Group (CLMG) has announced its partnership with Dragonfly Biosciences which produces a range of CBD oils and skincare products. As an end-to-end marketing partner, CLMG will assist Dragonfly Biosciences in launching its ASX listing and establishing a presence in the Australian Market.
Dragonfly Biosciences intends to raise $5 million AUS dollars at $0.20 cents per share, with the financing being jointly led by Finexia Securities and RM Corporate Finance Pty Limited. According to Fortune Business Insights, the global CBD market is estimated to be worth USD $3.6 billion growing to USD $55 billion by 2028.
Dragonfly Biosciences chose CLMG as their marketing and advertising partner due to the unique advantage of having production, campaign management and media buying all under one roof. This streamlined approach simplifies the process for Dragonfly Biosciences as an international company, ensuring an efficient marketing strategy.
Currently, Dragonfly Biosciences and CLMG are collaborating on a creative-led multichannel marketing strategy tailored to support their entry into the Australian market.
“We are thrilled to partner with Dragonfly Biosciences for their exciting launch into the Australian market, trading on the ASX,” said Misha Vaxman, CRO and co-founder of CLMG. “With our dedicated team of marketing professionals and being able to provide strategy, production, performance and media buying resources under a single roof we are confident in our ability and committed to driving the Dragonfly’s success beyond its initial launch in Australia, cementing a continued presence.”
Dragonfly Biosciences chief executive, Regan Saveall on the company’s launch into Australia notes, “I am excited and proud to announce the company’s entry into Australia. With the help of the CLMG team, we are confident that our robust marketing strategy will be well received by all our stakeholders as well as the Australian people.”
–
Top Image: Regan Saveall